Literature DB >> 25023547

Surgical approaches to advanced gallbladder cancer : a 40-year single-institution study of prognostic factors and resectability.

Ryota Higuchi1, Takehiro Ota, Tatsuo Araida, Hideki Kajiyama, Takehisa Yazawa, Toru Furukawa, Tatsuya Yoshikawa, Ken Takasaki, Masakazu Yamamoto.   

Abstract

PURPOSE: The aim was to evaluate prognostic factors and factors associated with the resectability of advanced gallbladder cancer (GBC).
METHODS: This was a single-institution retrospective review of 274 consecutive surgically-treated cases of advanced GBC (excluding incidental GBC and early GBC). Univariate and multivariate analysis were performed to assess prognostic variables. R0 resection and survival rates were investigated for each local extension factor.
RESULTS: Long-term survival was uncommon among patients with multiple liver metastases (H2-3: n = 22; 2-year survival, 0 %), dissemination (P1-3: n = 16; 3-year survival, 0 %), invasion through the hepatoduodenal ligament (Binf3: n = 45; 5-year survival, 4.6 %), or group 3 lymph node (LN) metastasis including of the para-aortic LN (N3: n = 52; 13.7 %). Long-term survival rates did not differ significantly between patients who did and did not undergo bile duct resection or pancreaticoduodenectomy. Survival did not differ significantly according to the type of hepatectomy performed.
CONCLUSION: Surgery may not be indicated for patients with multiple liver metastasis, dissemination, Binf3, or visible para-aortic LN metastasis. Furthermore, it is important to achieve R0 surgery in cases of GBC.

Entities:  

Mesh:

Year:  2014        PMID: 25023547     DOI: 10.1245/s10434-014-3885-1

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  13 in total

1.  Preoperative CT findings for prediction of resectability in patients with gallbladder cancer.

Authors:  Seo-Youn Choi; Jung Hoon Kim; Hyun Jeong Park; Joon Koo Han
Journal:  Eur Radiol       Date:  2019-06-28       Impact factor: 5.315

2.  Preoperative serum fibrinogen as a valuable predictor in the nomogram predicting overall survival of postoperative patients with gallbladder cancer.

Authors:  Ziyi Yang; Tai Ren; Shilei Liu; Chen Cai; Wei Gong; Yijun Shu
Journal:  J Gastrointest Oncol       Date:  2021-08

3.  The role of microRNAs in gallbladder cancer.

Authors:  Ganghua Yang; Lei Zhang; Ruixiang Li; Lin Wang
Journal:  Mol Clin Oncol       Date:  2016-05-11

4.  Long-Term Outcomes and Prognostic Factors in Advanced Gallbladder Cancer: Focus on the Advanced T Stage.

Authors:  Chen Chen; Zhimin Geng; Haoxin Shen; Huwei Song; Yaling Zhao; Guanjun Zhang; Wenzhi Li; Li Ma; Lin Wang
Journal:  PLoS One       Date:  2016-11-15       Impact factor: 3.240

5.  Stathmin 1 expression predicts prognosis and benefits from adjuvant chemotherapy in patients with gallbladder carcinoma.

Authors:  Xiaobo Bo; Jie Wang; Qiang Fu; Yueqi Wang; Houbao Liu; Jiejie Xu
Journal:  Oncotarget       Date:  2017-07-27

6.  Role of common bile duct resection in T2 and T3 gallbladder cancer patients.

Authors:  Jin Hong Lim; Jae Uk Chong; Sung Hoon Kim; Seung Woo Park; Jin Sub Choi; Woo Jung Lee; Kyung Sik Kim
Journal:  Ann Hepatobiliary Pancreat Surg       Date:  2018-02-26

7.  Examination of Prognostic Factors Affecting Long-Term Survival of Patients with Stage 3/4 Gallbladder Cancer without Distant Metastasis.

Authors:  Ryota Higuchi; Takehisa Yazawa; Shuichirou Uemura; Yutaro Matsunaga; Takehiro Ota; Tatsuo Araida; Toru Furukawa; Masakazu Yamamoto
Journal:  Cancers (Basel)       Date:  2020-07-27       Impact factor: 6.639

8.  Estimating survival benefit of adjuvant therapy based on a Bayesian network prediction model in curatively resected advanced gallbladder adenocarcinoma.

Authors:  Zhi-Min Geng; Zhi-Qiang Cai; Zhen Zhang; Zhao-Hui Tang; Feng Xue; Chen Chen; Dong Zhang; Qi Li; Rui Zhang; Wen-Zhi Li; Lin Wang; Shu-Bin Si
Journal:  World J Gastroenterol       Date:  2019-10-07       Impact factor: 5.742

9.  Surgical treatment of gallbladder cancer: An eight-year experience in a single center.

Authors:  Yasuyuki Kamada; Tomohide Hori; Hidekazu Yamamoto; Hideki Harada; Michihiro Yamamoto; Masahiro Yamada; Takefumi Yazawa; Masaki Tani; Asahi Sato; Ryotaro Tani; Ryuhei Aoyama; Yudai Sasaki; Masazumi Zaima
Journal:  World J Hepatol       Date:  2020-09-27

10.  Who benefits from R0 resection? A single-center analysis of patients with stage Ⅳ gallbladder cancer.

Authors:  Chen Chen; Lin Wang; Rui Zhang; Qi Li; Ya-Ling Zhao; Guan-Jun Zhang; Wen-Zhi Li; Zhi-Min Geng
Journal:  Chronic Dis Transl Med       Date:  2019-10-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.